Celebrex Long-Term Safety Monitoring Results Reassure FDA

Data from long-term Celebrex (celecoxib) post-marketing studies reassure FDA of the COX-2 inhibitor's safety, Acting Deputy Commissioner for Operations Janet Woodcock, MD, said